Recovery Trial
‘Recovery Trial’ finds anti-arthritis drug reduces severe COVID-19 mortality
The trial found that Baricitinib reduces the mortality of hospitalized patients by 13%. Baricitinib inhibits the enzymes of a specific family of enzyme called the Janus Kinase (JAK) family
- Google employees lead sit-ins protesting company’s complicity in genocide
- Israeli tourists attack vigil in Cusco in support of Palestine
- During Red April, Brazil’s MST restates the importance of agrarian reform
- German authorities’ crackdown on Palestine Conference sparks widespread outrage
- As elections approach, India’s farmers count government’s broken promises
